Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant disease with a poor prognosis. Among the treatment strategies for HCC, tumor immunotherapy (TIT) is a promising research hotspot, in which identifying novel immune-related biomarkers and selecting suitable patient population are urgent issues...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhen-Dong, Luo, Jia-Yuan, Ye, Yu-Ping, Dang, Yi-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248567/
https://www.ncbi.nlm.nih.gov/pubmed/37304539
http://dx.doi.org/10.21037/tcr-22-2304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248567/
https://www.ncbi.nlm.nih.gov/pubmed/37304539
http://dx.doi.org/10.21037/tcr-22-2304

Ejemplares similares